INTRODUCTION
One of the earliest responses to growth factors and many other agonists is the induction of a group of primary-response genes which are induced by the activation of pre-existing transcription factors (reviewed by Herschman [1] ). The induction of these genes can occur without protein synthesis and is generally transient in nature. This is reflected in a rapid rise in the mRNA level which peaks within 30 min to 1-2 h and quickly returns to the basal level within 3-5 h [2] [3] [4] . The behaviour of this response implies that the mRNA of the early primary-response genes may be intrinsically unstable. More importantly, it also indicates that the transcription of these genes must be terminated rather abruptly, shortly after the initial presentation of the stimulus. Furthermore, as the transcription of primary early-response genes often ceases while the inducing agent continues to be present outside the cell, some alterations in the intracellular signalling process must occur to prevent the inducing signal from reaching the nucleus. Exactly how the cell manages to terminate and desensitize its transcriptional response to the incoming signal is not well understood. In particular, whether the desensitization process reflects a general suppression of the transcriptional activity of the primary-response gene or affects an individual specific signal-transduction pathway has not been established.
We are interested in the potential role of various primaryresponse genes in the regulation of the proliferation and differentiation of skeletal-muscle cells. We have reported previously that treatment with growth factors and other agents induces a number of primary-response genes in a variety of cell lines [4] [5] [6] . One of these genes, TISI (also known as nur77, N10), encodes an orphan receptor-like transcription factor [7] [8] [9] . The rat homologue of TISI, NGFIB, has been found recently to regulate the expression of the gene encoding the steroidogenic enzyme 21-hydroxylase [10] , and may also recognize a sequence element in the 5' flanking region of the acetylcholine receptor y-subunit gene [11] . The human homologue of TISI, NAK-1, has been isolated from a fetal muscle cDNA library [12] , and the expression level of TIS1 appeared to increase in skeletal-muscle occurred at the level of the receptor, as agents that either bypass the adrenergic receptor or activate alternative signalling pathways were able to induce TIS1 expression in the desensitized cells. However, stimulation by agents that directly activate intracellular enzymes also resulted in the signal-transduction-pathway-specific desensitization of TISI inducibility. Our results suggest that the pathway-specific nature of the desensitization process may be important for directing an integrated response to multiple physiological stimuli.
tissue during murine postnatal development [13] . Moreover, a recent study showed that TISI expression in vivo in the mouse adrenal gland may be under neuroendocrine regulation [14] . Thus, although TISI was originally identified as a mitogeninducible gene, these findings suggest that hormone-regulated expression of TISI may play a role in mediating the transcriptional responses of skeletal-muscle tissue to changes in the physiological environment. In agreement with such an hypothesis, we report here that the TIS1 mRNA was induced by the adrenergic agonist isoprenaline in the C2C12 mouse skeletalmuscle cell line. We showed that the induction of TIS1 occurred in a transient manner, as might be expected from the results of previous studies. Interestingly, termination of the transcriptional response to isoprenaline was accompanied by the desensitization of the isoprenaline receptor, as TISI expression was no longer induced by re-addition of the agonist, but remained inducible by agents that either bypass the membrane receptor or activate alternative signalling pathways. Moreover, pretreatment with pharmacological agents that stimulate TISI expression by activating intracellular enzymes also resulted in an attenuation of the induction response in a signal-transduction-pathway-specific manner. Taken together, the results from this study suggest that multiple mechanisms are involved in terminating the TISIinduction signal in a pathway-specific manner at both receptor and post-receptor levels. 
Plasmids
The derivation and properties of the TISlI recombinant cDNA plasmids have been described previously [4] . The plasmid pCHOb which recognizes a constitutively expressed mRNA species [15] was used as a probe to normalize for RNA loading and transfer as described earlier [4] . [2] [3] [4] , the induction of TISI occurred rapidly, reaching a peak by 0.5-1 h, but returned to basal level by 4 19 -30 h of forskolin pretreatment, the level of induction was less than that observed in cells that had not been previously exposed to forskolin. We examined next the recovery of TISI inducibility after forskolin removal. Cells were pretreated with the latter for 4 h, then rinsed and fed with growth medium without forskolin. The inducibility of TISI by forskolin was assessed from 4 to 45 h after the medium change. As shown in Figure 4 (c), the recovery of TISI inducibility appeared to be a rather slow process. Although some induction of TISI was evident by 8 h after removal of forskolin, TISI inducibility was not completely restored until about 40 h after the medium change. Interestingly, a substantial return of TISI inducibility was observed by 36 h after the start of forskolin pretreatment even if the medium was left unchanged, presumably because of the gradual inactivation of forskolin in the incubation medium (results not shown).
DISCUSSION
The primary-response gene TISI encodes a nuclear receptor-like transcription factor that is rapidly induced by growth factors and a variety of other agents [7, [17] [18] [19] . Results from a number of studies suggest that altered expression of TIS1 in response to external stimuli may have important modulating influences on the expression of tissue-specific genes [10, 11] . We report in this study that TISI can be induced in the C2C12 skeletal-muscle cell line in response to the ,-adrenergic agonist isoprenaline ( Figure   1 ). As chronic stimulation by adrenergic agonists has been shown to cause skeletal-muscle hypertrophy and alter the metabolism of specific muscle fibre types in experimental animals [20] , the inducibility of TISI by isoprenaline in C2C12 cells suggests that TISI may mediate some of the secondary transcriptional responses to f-adrenergic stimulation in muscle tissues.
Consistent with the induction characteristics of a primaryresponse gene, the induction ofTIS 1 by isoprenaline was transient (Figure 1 a) . Moreover, as addition of fresh isoprenaline failed to re-induce TISI gene expression (Figure 2 ), the cells appeared to have become refractory to the stimulatory effect of the adrenergic agonist. This refractoriness to further stimulation has at least two alternative explanations. First, induction of the earlyresponse gene TIS1 can be repressed at a step after the convergence of various signal-transduction pathways such that it can no longer be stimulated by any inducing ligand. Alternatively, the transcription of TISI may be repressed in a pathway-specific manner. Our data (Figure 2) showing that agents that presumably stimulate TISI expression through non-cyclic AMP-signalling pathways could induce TISI in isoprenaline-pretreated cells indicate that the attenuation of the TIS1-induction response is pathway-specific. In addition, as bypassing the cell-surface receptors by directly activating adenylate cyclase with forskolin also induced TISI in isoprenaline-pretreated cells (Figure 2) , the transient nature of TIS1 induction by isoprenaline may be due in part to the desensitization ofthe ,8-adrenergic receptor. A number of distinct mechanisms have been shown previously to cause similar desensitization of adrenergic and other G-protein-coupled receptors (reviewed in ref. [21] ).
Additional data suggest that the signal-transduction cascade leading to TISI expression could also be uncoupled at some step(s) distal to the cell-surface receptor. We showed in Figure 3 , for example, that pretreatment with agents such as forskolin and PMA, which act intracellularly to bypass membrane receptors, nonetheless resulted in the 'desensitization' of TIS1 induction.
The desensitization again occurred in a ligand-specific manner, in response to agents that activate other signal-transduction pathways. The desensitization process occurred very rapidly and persisted for up to 11 h in the presence of forskolin (Figures 4a  and 4b ). In contrast, removing the inducing ligand resulted in a slow recovery of the induction response (Figure 4c) .
Relatively little attention has been paid to the mechanisms responsible for the attenuation of the transcription of primaryresponse genes. Gius et al. [22] reported that expression of the primary-response gene egr-J can be down-regulated by overexpression of c-fos, and suggested that induction of c-fos may serve as a feedback mechanism to prevent the continuous activation offos and other primary-response genes. This model of inhibition, however, does not readily explain the pathwayspecific nature of the attenuation observed in our experiments. As c-fos is induced in common by a large number of different stimulating agents, transcriptional repression by c-fos would not be expected to discriminate among inducers triggering different signal-transduction pathways. More recently, Hagiwara et al. [23] reported that the attenuation of cyclic AMP-induced gene induction may be due to the dephosphorylation of cyclic AMPresponsive element (CRE)-binding protein (CREB) by protein phosphatase 1. According to their data, okadaic acid, which is a potent inhibitor of this enzyme, potentiated CRE-mediated gene induction, but had little or no effect on gene expression regulated through the PMA-responsive element. Similarly, Wadzinski et al. [24] also demonstrated that okadaic acid can enhance the cyclic AMP-mediated transcriptional response of the phosphoenolpyruvate carboxykinase promoter but argued on the basis of other evidence that protein phosphatase 2a rather than protein phosphatase 1 may be responsible for CREB dephosphorylation and attenuation of the inductive response. The TISI 5' flanking region, however, does not contain any consensus CRE [9, 19, 25] . Although it is possible that a non-consensus CRE might be involved in TIS1 expression, there is no direct evidence to date demonstrating the involvement of CREB in the cyclic AMP-dependent induction of TIS1. It is thus not clear whether the previously reported dephosphorylation of CREB would necessarily be applicable to the attenuation of TISI induction after forskolin pretreatment. In this regard, the slow recovery of TISI inducibility after removal of forskolin suggests that the desensitization phenomenon may have resulted from processes other than rapidly reversible post-translational modification.
The precise mechanism responsible for the pathway-specific desensitization of TISI response after the short (4 h) PMA pretreatment is also not clearly understood. Although it is well established that prolonged treatment with PMA causes the down-regulation ofprotein kinase C activity [26] and degradation of the enzyme [27] , the rapidity of the loss of TISI inducibility presumably cannot be accounted for by the down-regulation of the classic protein kinase C isoenzymes. That some novel isoforms of protein kinase C that are down-regulated more rapidly might be responsible for the PMA-mediated induction and desensitization of TIS1 expression cannot at present be completely ruled out.
In a related study, Yu et al. [28] recently demonstrated that overexpression of oncoproteins involved in the tyrosine kinase signalling pathway also resulted in the reduced serum inducibility of several early-response genes including TIS 1. Thus stimulation of many different signal-transduction pathways leading to earlyresponse-gene expression can all result in the desensitization of the induction response. Data from the present study indicate that the desensitization occurs in a signal-transduction-pathwayspecific manner. These observations emphasize the importance of the attenuation process in fine-tuning the expression of primary-response genes in response to different stimuli. The and the desensitized cells could still be induced to express TIS I Pathway-specific desensitization of primary-response-gene expression pathway-specific nature of the desensitization ensures that the early-response genes will not be overexpressed in response to a single type of stimulus but yet remain poised to respond to other types of signal that might further impinge on the cell, thus allowing the cell to integrate the incoming signals to mount a coherent physiological response.
